FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

704312008: Substance with Janus kinase inhibitor mechanism of action (substance)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3012791012 Janus kinase inhibitor en Synonym Active Entire term case sensitive SNOMED CT core module
3520758018 Substance with Janus kinase inhibitor mechanism of action (substance) en Fully specified name Active Only initial character case insensitive SNOMED CT core module
3520928016 Substance with Janus kinase inhibitor mechanism of action en Synonym Active Only initial character case insensitive SNOMED CT core module


13 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance with Janus kinase inhibitor mechanism of action Is a Substance with protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Substance with Janus kinase inhibitor mechanism of action Has disposition Janus kinase inhibitor true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Tofacitinib Is a True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ruxolitinib Is a True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing Janus kinase inhibitor Has active ingredient True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier 1
Baricitinib Is a True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Tofacitinib citrate Is a True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ruxolitinib phosphate Is a True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Fedratinib Is a True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Upadacitinib Is a True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Fedratinib hydrochloride Is a True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Upadacitinib hemihydrate Is a True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Upadacitinib Is a False Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Brolucizumab Is a False Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Abrocitinib Is a True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Filgotinib Is a True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Fedratinib Is a False Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Brolucizumab Is a True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Filgotinib maleate Is a True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Baricitinib Is a False Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Baricitinib Has active ingredient False Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Baricitinib 4mg tablets Has active ingredient False Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) Has active ingredient True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Baricitinib 2mg tablets Has active ingredient False Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Olumiant 2mg tablets (Eli Lilly and Company Ltd) Has active ingredient True Substance with Janus kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start